Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy

2013104 citationsJournal Articlehybrid Open Access

Authors

Shunsuke Mori · Kumamoto Orthopedic Surgery Hospital

Yukitaka Ueki · Sasebo City General Hospital

Yukihiro Akeda · Osaka University

Naoyuki Hirakata · Sasebo City General Hospital

Motohiro Oribe

Yoshiki Shiohira · Tomishiro Central Hospital

Toshihiko Hidaka · University of Miyazaki Hospital

Abstract

TCZ does not impair PPV23 immunogenicity in RA patients, whereas antibody responses may be reduced when TCZ is used as a combination therapy with MTX.

Topics & Keywords

Immunodeficiency and Autoimmune Disorders Monoclonal and Polyclonal Antibodies Research Chronic Lymphocytic Leukemia Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of the Rheumatic Diseases

Volume 72, Issue 8, pp. 1362-1366

DOI: 10.1136/annrheumdis-2012-202658

Field-Weighted Citation Impact: 4.85